Healthy Volunteer Study
NCT07270783 · Status: ACTIVE_NOT_RECRUITING · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 36
Last updated 2026-05-05
Summary
Double Blinded Healthy Volunteer study evaluating D-2570 against placebo in various doses.
Conditions
- Healthy Volunteer
Interventions
- DRUG
-
D-2570
D-2570
- DRUG
-
Placebo
Sponsors & Collaborators
-
InventisBio Co., Ltd
lead INDUSTRY
Study Design
- Allocation
- RANDOMIZED
- Purpose
- OTHER
- Masking
- QUADRUPLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 55 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2025-12-04
- Primary Completion
- 2026-06-30
- Completion
- 2026-08-31
- FDA Drug
- Yes
Countries
- United States
Study Locations
More Related Trials
-
Phase I Study of D-0120 to Evaluate Safety and PK/PD Study in Healthy Volunteers
NCT04097405 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of E2027 in Healthy Subjects
NCT02873156 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Establish Safety and Maximum Tolerated Dose of IV Trehalose in Healthy Subjects
NCT02725957 ·Status: COMPLETED ·Phase: PHASE1
-
A Study of Single Ascending Doses of PF-07258669 in Healthy Adult Participants
NCT04628793 ·Status: COMPLETED ·Phase: PHASE1
-
A Multiple Ascending Dose Study to Investigate Safety of KBP-7072 in Healthy Subjects
NCT04532957 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Assess the Safety, Tolerability, and Pharmacokinetics of E2730 in Healthy Participants
NCT03451890 ·Status: COMPLETED ·Phase: PHASE1
-
Study of MORF 057 to Evaluate Single and Multi Ascending Doses in Healthy Volunteers
NCT04580745 ·Status: COMPLETED ·Phase: PHASE1
-
Study Evaluating the Safety and Pharmacokinetics of Ascending Single IV Doses of ERB-257
NCT00722501 ·Status: COMPLETED ·Phase: PHASE1
-
Clinical Trial of GX-I7 in Healthy Volunteers
NCT02860715 ·Status: COMPLETED ·Phase: PHASE1
-
Phase I Clinical Study to Investigate the Pharmacokinetics and Safety/Tolerability of DA-7218 in Healthy Male Volunteers
NCT02097043 ·Status: COMPLETED ·Phase: PHASE1
-
Study of the Safety, Tolerability, and Pharmacokinetics of LV232 Capsules in Chinese Healthy Volunteers
NCT06070857 ·Status: COMPLETED ·Phase: PHASE1
-
Randomized, Placebo-Controlled, Double-Blind, Ascending Single and Multiple Dose Study to Evaluate the Safety, Tolerability and Pharmacokinetics of BMS-963272 in Healthy Subjects
NCT02327273 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Assess the Safety, Tolerability, and Pharmacokinetics of a Single Ascending Dose of AZD0292 In Healthy Participants
NCT06311760 ·Status: COMPLETED ·Phase: PHASE1
-
SAD Evaluation of Safety, Tolerability, PK, and PD of MDI-2517 in Healthy Participants
NCT06453824 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Determine the Safety, Tolerability, and Pharmacokinetics of GDC-0310 in Healthy Volunteers
NCT02742779 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Assess the Safety, Tolerability and Pharmacokinetics After Single Ascending Intravenous Doses of AZD2927 in Healthy Male Volunteers
NCT01264250 ·Status: COMPLETED ·Phase: PHASE1
-
Safety, Tolerability and Pharmacokinetics of Single and Multiple Oral Administration of HS-10356 in Healthy Volunteers
NCT04652297 ·Status: UNKNOWN ·Phase: PHASE1
-
A Study to Assess the Safety, Tolerability, Pharmacokinetics, Immunogenicity, and Pharmacodynamics of E2025 in Healthy Participants
NCT05726851 ·Status: COMPLETED ·Phase: PHASE1
-
A Randomized, Double Blind Placebo-Controlled, Single Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of BMS-986166 in Healthy Subjects
NCT02790125 ·Status: COMPLETED ·Phase: PHASE1
-
Safety, Tolerability, and Pharmacokinetics of DD-S052P in Healthy Volunteers
NCT07347223 ·Status: COMPLETED ·Phase: PHASE1
-
Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Ascending Dose of TT-00920 in Healthy Subjects
NCT05043792 ·Status: COMPLETED ·Phase: PHASE1
-
A Study of IW-6463 in Healthy Volunteers
NCT03856827 ·Status: COMPLETED ·Phase: PHASE1
-
A Multiple Ascending-Dose Study of RG7625 in Healthy Volunteers
NCT02521610 ·Status: COMPLETED ·Phase: PHASE1
-
AZD8529 Single Ascending Dose Study
NCT00755378 ·Status: COMPLETED ·Phase: PHASE1
-
Phase I Multiple Ascending Dose Study for AZD 7268 in Healthy Volunteers
NCT00861718 ·Status: COMPLETED ·Phase: PHASE1